Tikun Olam - Cannbit Pharmaceuticals Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was ILS 21.659 million. Operating income was ILS 33.883 million compared to ILS 9.948 million a year ago. Net loss was ILS 32.941 million compared to ILS 10.888 million a year ago. Basic earnings per share from continuing operations was ILS 0.96 compared to ILS 0.59 a year ago.